Correction: "Biochemical and structural properties of mouse kynurenine aminotransferase III" [Mol Cell Biol 38 e00099-18] DOI: 10.1128/MCB.00099-18;Biochemical and structural properties of mouse kynurenine aminotransferase III

Molecular and Cellular Biology

Volumn 29, Issue 3, 2009, Pages 784-793

  Han, Qian ^a   Robinson, Howard ^b   Cai, Tao ^c   Tagle, Danilo A ^d   Li, Jianyong ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; AMINO ACID; COMPLEMENTARY DNA; CYSTEINE; GLUTAMINE; HISTIDINE; KYNURENINE AMINOTRANSFERASE; KYNURENINE AMINOTRANSFERASE III; LEUCINE; METHIONINE; UNCLASSIFIED DRUG; AMINOTRANSFERASE; KYNURENINE; KYNURENINE OXOGLUTARATE TRANSAMINASE; KYNURENINE-OXOGLUTARATE TRANSAMINASE; PROTEIN SUBUNIT; PYRIDOXAL 5 PHOSPHATE;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DNA LIBRARY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; GENE AMPLIFICATION; GENE EXPRESSION SYSTEM; HIGH TEMPERATURE; INSECT CELL; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ANALYSIS; TRANSAMINATION; AMINATION; ANIMAL; CATALYSIS; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE; STRUCTURE ACTIVITY RELATION; TEMPERATURE; X RAY CRYSTALLOGRAPHY;

HEXAPODA; MAMMALIA;

AMINATION; ANIMALS; CATALYSIS; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; GLUTAMINE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; KYNURENINE; MICE; PROTEIN STRUCTURE, SECONDARY; PROTEIN SUBUNITS; PYRIDOXAL PHOSPHATE; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TEMPERATURE; TRANSAMINASES;

EID: 59249105861     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00099-18     Document Type: Erratum

References (60)

1. Alkondon, M., E. F. Pereira, P. Yu, E. Z. Arruda, L. E. Almeida, P. Guidetti, W. P. Fawcett, M. T. Sapko, W. R. Randall, R. Schwarcz, D. A. Tagle, and E. X. Albuquerque. 2004. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J. Neurosci. 24:4635-4648.
2. Baran, H., G. Amann, B. Lubec, and G. Lubec. 1997. Kynurenic acid and kynurenine aminotransferase in heart. Pediatr. Res. 41:404-410.
3. Baran, H., N. Cairns, B. Lubec, and G. Lubec. 1996. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Life Sci. 58:1891-1899.
4. Baran, H., E. Okuno, R. Kido, and R. Schwarcz. 1994. Purification and characterization of kynurenine aminotransferase I from human brain. J. Neurochem. 62:730-738.
5. Beal, M. F., W. R. Matson, K. J. Swartz, P. H. Gamache, and E. D. Bird. 1990. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J. Neurochem. 55:1327-1339.
6. Birch, P. J., C. J. Grossman, and A. G. Hayes. 1988. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur. J. Pharmacol. 154:85-87.
7. Chon, H., H. Matsumura, Y. Koga, K. Takano, and S. Kanaya. 2005. Crystal structure of a human kynurenine aminotransferase II homologue from Pyrococcus horikoshii OT3 at 2.20 A resolution. Proteins 61:685-688.
8. Colombari, E., M. A. Sato, S. L. Cravo, C. T. Bergamaschi, R. R. Campos, Jr., and O. U. Lopes. 2001. Role of the medulla oblongata in hypertension. Hypertension 38:549-554.
9. Cooper, A. J., J. T. Pinto, B. F. Krasnikov, Z. V. Niatsetskaya, Q. Han, J. Li, D. Vauzour, and J. P. Spencer. 2008. Substrate specificity of human glu- tamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Arch. Biochem. Biophys. 474:72-81.
10. DeLano, W. L. 2002. The PyMOL molecular graphics system. Delano Scientific, San Carlos, CA.
11. Erhardt, S., K. Blennow, C. Nordin, E. Skogh, L. H. Lindstrom, and G. Engberg. 2001. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci. Lett. 313:96-98.
12. Erhardt, S., L. Schwieler, L. Nilsson, K. Linderholm, and G. Engberg. 2007. The kynurenic acid hypothesis of schizophrenia. Physiol. Behav. 92:203-209.
13. Goto, M., R. Omi, I. Miyahara, A. Hosono, H. Mizuguchi, H. Hayashi, H. Kagamiyama, and K. Hirotsu. 2004. Crystal structures of glutamine: phenylpyruvate aminotransferase from Thermus thermophilus HB8: induced fit and substrate recognition. J. Biol. Chem. 279:16518-16525.
14. Grishin, N. V., M. A. Phillips, and E. J. Goldsmith. 1995. Modeling of the spatial structure of eukaryotic ornithine decarboxylases. Protein Sci. 4:1291-1304.
15. Guidetti, P., L. Amori, M. T. Sapko, E. Okuno, and R. Schwarcz. 2007. Mitochondrial aspartate aminotransferase: a third kynurenate-producing en-zyme in the mammalian brain. J. Neurochem. 102:103-111.
16. Guidetti, P., E. Okuno, and R. Schwarcz. 1997. Characterization of rat brain kynurenine aminotransferases I and II. J. Neurosci. Res. 50:457-465.
17. Guidetti, P., P. H. Reddy, D. A. Tagle, and R. Schwarcz. 2000. Earlykynurenergic impairment in Huntington's disease and in a transgenic animal model. Neurosci. Lett. 283:233-235.
18. Guillemin, G. J., S. J. Kerr, and B. J. Brew. 2005. Involvement of quinolinic acid in AIDS dementia complex. Neurotox. Res. 7:103-123.
19. Han, Q., T. Cai, D. A. Tagle, H. Robinson, and J. Li. 2008. Substrate specificity and structure of human aminoadipate aminotransferase/ kynuren- ine aminotransferase II. Biosci. Rep. 28:205-215.
20. Han, Q., J. Fang, and J. Li. 2002. 3-Hydroxykynurenine transaminase identity with alanine glyoxylate transaminase. A probable detoxification protein in Aedes aegypti. J. Biol. Chem. 277:15781-15787.
21. Han, Q., J. Fang, and J. Li. 2001. Kynurenine aminotransferase and glu- tamine transaminase K of Escherichia coli: identity with aspartate amino- transferase. Biochem. J. 360:617-623.
22. Han, Q., Y. G. Gao, H. Robinson, H. Ding, S. Wilson, and J. Li. 2005. Crystal structures of Aedes aegypti kynurenine aminotransferase. FEBS J. 272:2198-2206.
23. Han, Q., Y. G. Gao, H. Robinson, and J. Li. 2008. Structural insight into the mechanism of substrate specificity of Aedes kynurenine aminotransferase. Biochemistry 47:1622-1630.
24. Han, Q., and J. Li. 2004. Cysteine and keto acids modulate mosquito kynuren- ine aminotransferase catalyzed kynurenic acid production. FEBS Lett. 577: 381-385.
25. Han, Q., J. Li, and J. Li. 2004. pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur. J. Biochem. 271: 4804-4814.
26. Han, Q., H. Robinson, and J. Li. 2008. Crystal structure of human kynuren- ine aminotransferase II. J. Biol. Chem. 283:3567-3573.
27. Hilmas, C., E. F. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E. X. Albuquerque. 2001. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21:7463-7473.
28. Holm, L., and C. Sander. 1993. Proteinstructure comparisonbyalignmentof distance matrices. J. Mol. Biol. 233:123-138.
29. Ito, S., K. Komatsu, K. Tsukamoto, and A. F. Sved. 2000. Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. Hypertension 35:413-417.
30. Jansonius, J. N. 1998. Structure, evolution and action of vitamin B6-depen- dent enzymes. Curr. Opin. Struct. Biol. 8:759-769.
31. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47:110-119.
32. Kabsch, W. 1976. Crystal physics, diffraction, theoretical and general crystallography. Acta Crystallogr. A 32:922-923.
33. Kack, H., J. Sandmark, K. Gibson, G. Schneider, and Y. Lindqvist. 1999. Crystal structure of diaminopelargonic acid synthase: evolutionary relationships between pyridoxal-5'-phosphate-dependent enzymes. J. Mol. Biol. 291: 857-876.
34. Kwok, J. B., R. Kapoor, T. Gotoda, Y. Iwamoto, Y. Iizuka, N. Yamada, K. E. Isaacs, V. V. Kushwaha, W. B. Church, P. R. Schofield, and V. Kapoor. 2002. A missense mutation in kynurenine aminotransferase-1 in spontaneously hypertensive rats. J. Biol. Chem. 277:35779-35782.
35. Laskowski, R. A., M. W. Macarthur, D. S. Moss, and J. M. Thornton. 1993. Procheck-a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
36. Leeson, P. D., and L. L. Iversen. 1994. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J. Med. Chem. 37:4053-4067.
37. Malherbe, P., D. Alberati-Giani, C. Kohler, and A. M. Cesura. 1995. Identification of a mitochondrial form of kynurenine aminotransferase/ glutamine transaminase K from rat brain. FEBS Lett. 367:141-144.
38. Mehta, P. K., T. I. Hale, and P. Christen. 1993. Aminotransferases: demonstration of homology and division into evolutionary subgroups. Eur. J. Biochem. 214:549-561.
39. Milart, P., E. M. Urbanska, W. A. Turski, T. Paszkowski, and R. Sikorski. 2001. Kynurenine aminotransferase I activity in human placenta. Placenta 22:259-261.
40. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crys-tallogr. D 53:240-255.
41. Okuno, E., M. Nakamura, and R. Schwarcz. 1991. Two kynurenine amino- transferases in human brain. Brain Res. 542:307-312.
42. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
43. Pereira, E. F., C. Hilmas, M. D. Santos, M. Alkondon, A. Maelicke, and E. X. Albuquerque. 2002. Unconventional ligands and modulators of nicotinic receptors. J. Neurobiol. 53:479-500.
44. Perkins, M. N., and T. W. Stone. 1982. Aniontophoretic investigation ofthe actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247:184-187.
45. Perrakis, A., T. K. Sixma, K. S. Wilson, and V. S. Lamzin. 1997. wARP: improvement and extension of crystallographic phases by weighted averaging of multiple refined dummy atomic models. Acta Crystallogr. D 53:448-455.
46. Ross, M. H., J. O. Ely, and J. G. Archer. 1951. Alkaline phosphatase activity and pH optima. J. Biol. Chem. 192:561-568.
47. Rossi, F., S. Garavaglia, V. Montalbano, M. A. Walsh, and M. Rizzi. 2008. Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia. J. Biol. Chem. 283:3559-3566.
48. Rossi, F., Q. Han, J. Li, J. Li, and M. Rizzi. 2004. Crystal structure ofhuman kynurenine aminotransferase I. J. Biol. Chem. 279:50214-50220.
49. Schmidt, W., P. Guidetti, E. Okuno, and R. Schwarcz. 1993. Characterization of human brain kynurenine aminotransferases using [3H]kynurenine as a substrate. Neuroscience 55:177-184.
50. Schneider, G., H. Kack, and Y. Lindqvist. 2000. The manifold of vitamin B6 dependent enzymes. Structure 8:R1-R6.
51. Schwarcz, R., and R. Pellicciari. 2002. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 303:1-10.
52. Schwarcz, R., A. Rassoulpour, H. Q. Wu, D. Medoff, C. A. Tamminga, and R. C. Roberts. 2001. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50:521-530.
53. Stone, T. W. 2007. Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur. J. Neurosci. 25:2656-2665.
54. Stone, T. W., and M. N. Perkins. 1984. Actions of excitatory amino acids and kynurenic acid in the primate hippocampus: a preliminary study. Neurosci. Lett. 52:335-340.
55. Takeuchi, F., H. Otsuka, and Y. Shibata. 1983. Purification, characterization and identification of rat liver mitochondrial kynurenine aminotransferase with alpha-aminoadipate aminotransferase. Biochim. Biophys. Acta 743: 323-330.
56. Vagin, A., and A. Teplyakov. 1997. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30:1022-1025.
57. Wang, J., N. Simonavicius, X. Wu, G. Swaminath, J. Reagan, H. Tian, and L. Ling. 2006. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J. Biol. Chem. 281:22021-22028.
58. Widner, B., F. Leblhuber, J. Walli, G. P. Tilz, U. Demel, and D. Fuchs. 2000. Tryptophan degradation and immune activation in Alzheimer's disease. J. Neural Transm. 107:343-353.
59. Yu, P., N. A. Di Prospero, M. T. Sapko, T. Cai, A. Chen, M. Melendez-Ferro, F. Du, W. O. Whetsell, Jr., P. Guidetti, R. Schwarcz, and D. A. Tagle. 2004. Biochemical and phenotypic abnormalities in kynurenine aminotransferase Il-deficient mice. Mol. Cell. Biol. 24:6919-6930.
60. Yu, P., Z. Li, L. Zhang, D. A. Tagle, and T. Cai. 2006. Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 365:111-118.